OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 10,198 results

Filters: Omicron Variant

OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern mounting worldwide fear.
Vikram Thakur, Radha Kanta Ratho
J Med Virol. 05, 2022.94(5):1821-1824 Print-Electronic
Source:PubMed
PMID: 34936120 doi:10.1002/jmv.27541
BA.1 and BA.2 sub-lineages of Omicron variant have comparable replication kinetics and susceptibility to neutralization by antibodies
Singh, J.; Panwar, A.; Anantharaj, A.; Rani, C.; Bhardwaj, M.; Kumar, P.; Pargai, K.; Chattopadhyay, P.; Devi, P.; Maurya, R.; Mishra, P.; Pandey, A. K.; Pandey, R.; Medigeshi, G. R.
medrxiv. 2022-06-06. Preprint
Source:medrxiv
PPRID: 10.1101/2022.01.28.22269990v3 doi:NA
Across-the-board review on Omicron SARS-CoV-2 variant.
Rufaida Wasim, Asad Ahmad
Inflammopharmacology. Jan, 2025.33(1):1-10 Print-Electronic
Source:PubMed
PMID: 39714724 doi:10.1007/s10787-024-01627-4
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Bojkova, D.; Widera, M.; Ciesek, S.; Wass, M. N.; Michaelis, M.; Cinatl, J. N.
biorxiv. 2022-01-04. Preprint
Source:biorxiv
PPRID: 10.1101/2022.01.03.474773v1 doi:10.1038/s41422-022-00619-9
Infection with Omicron variant generates neutralizing antibodies to BA.1 and BA.2 sub-lineages and induces higher levels of cross-neutralizing antibodies to Delta variant
Singh, J.; Shaman, H.; Singh, B.; Anantharaj, A.; Pargai, K.; Kumar, P.; Chattopadhyay, P.; Devi, P.; Maurya, R.; Mishra, P.; Kahlon, N.; Pandey, A. K.; Pandey, R.; Medigeshi, G. R.
medrxiv. 2022-03-07. Preprint
Source:medrxiv
PPRID: 10.1101/2022.01.28.22269990v2 doi:NA
Combating the SARS-CoV-2 Omicron variant with non-Omicron neutralizing antibodies
Wang, Y.; Zhang, X.; Liu, J.; Wang, Y.; Zhan, W.; Liu, M.; Zhang, M.; Wang, Q.; Liu, Q.; Zhu, T.-Y.; Wen, Y.; Chen, Z.; Zhao, J.; Wu, F.; Sun, L.; Huang, J.
biorxiv. 2022-01-31. Preprint
Source:biorxiv
PPRID: 10.1101/2022.01.30.478305v1 doi:NA
Omicron SARS-CoV-2 variant of concern: A review on its transmissibility, immune evasion, reinfection, and severity.
Md Mohsin, Sultan Mahmud
Medicine (Baltimore). May 13, 2022.101(19):e29165 Electronic
Source:PubMed
PMID: 35583528 doi:10.1097/MD.0000000000029165
Omicron-Specific and Bivalent Omicron-Containing Vaccine Candidates Elicit Potent Virus Neutralisation in the Animal Model
Abdoli, A.; Jamshidi, H.; Lari Baghal, M.; Taqavian, M.; Jalili, H.
biorxiv. 2023-02-20. Preprint
Source:biorxiv
PPRID: 10.1101/2022.02.11.480131v2 doi:NA
Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California
Lewnard, J. A.; Hong, V. X.; Patel, M. M.; Kahn, R.; Lipsitch, M.; Tartof, S. Y.
medrxiv. 2022-01-11. Preprint
Source:medrxiv
PPRID: 10.1101/2022.01.11.22269045v1 doi:NA
Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California
Lewnard, J. A.; Hong, V. X.; Patel, M. M.; Kahn, R.; Lipsitch, M.; Tartof, S. Y.
medrxiv. 2022-03-07. Preprint
Source:medrxiv
PPRID: 10.1101/2022.01.11.22269045v2 doi:NA
0